静脉利多卡因与硬膜外麻醉治疗创伤性肋骨骨折疼痛的比较:回顾性队列研究
结果显示两组在0-24小时和24-48小时疼痛评分降低程度相似,但静脉利多卡因组非椎管内阿片消耗更高,而计入椎管内阿片后硬膜外组总阿片消耗更高,提示静脉利多卡因可能具有阿片节约效应,可作为硬膜外禁忌或无法及时实施时的替代选择。
要点
- 静脉利多卡因与硬膜外麻醉在0-24小时和24-48小时疼痛评分降低程度相似。
- 静脉利多卡因组非椎管内阿片消耗显著高于硬膜外组。
- 计入椎管内阿片后,硬膜外组总阿片消耗更高,提示静脉利多卡因可能阿片节约。
核心结论
- 静脉利多卡因在降低疼痛评分方面与硬膜外麻醉相似,且计入椎管内阿片后可能具有阿片节约效应。
- 静脉利多卡因可作为硬膜外禁忌或无法及时实施硬膜外时的有效替代选择。
研究设计与样本
- 回顾性队列研究,纳入2011年6月1日至2016年6月1日一家学术型一级创伤中心收治的因急性肋骨骨折疼痛请疼痛科会诊的成人患者。
主要发现
- 基线数字疼痛评分静脉利多卡因组平均5.6,硬膜外组平均4.5,p=0.01;年龄、损伤严重程度和骨折肋骨数相似。
- 0-24小时和24-48小时疼痛评分降低程度两组相似(两个时段平均降幅均为静脉利多卡因-2.9 vs 硬膜外-2.3,p=0.19和p=0.17)。
- 非椎管内阿片消耗静脉利多卡因组更高:0-24小时98.6 vs 22.3 mg吗啡当量(MME),p=0.0005;24-48小时105.6 vs 18.9 MME,p<0.0001。
- 计入椎管内阿片后,硬膜外组总MME更高:0-24小时655.2 vs 98.6 MME,p<0.0001;24-48小时586 vs 105.6 MME,p=0.0001。
临床怎么用
- 对于创伤性肋骨骨折疼痛,静脉利多卡因可考虑作为硬膜外麻醉的替代方案。
- 尤其适用于存在硬膜外禁忌或无法及时实施硬膜外的患者。
局限性
- 回顾性研究设计。
- 基线疼痛评分两组存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Effective analgesia is essential in managing traumatic rib fractures. Intravenous lidocaine (IVL) is effective in treating perioperative pain, acute pain in the emergency department, cancer pain in hospice, and outpatient chronic neuropathic pain. Our study examined the associations between IVL versus epidural analgesia (EA) and pain for the treatment of acute rib fracture in the inpatient setting. METHODS: We performed a retrospective study involving adults admitted to an academic level I trauma center from June 1, 2011 to June 1, 2016 with consults to the pain service for acute rib fracture pain. Eighty-nine patients were included in the final analysis (54 IVL and 35 EA patients). Both groups had usual access to opioid medications. The primary outcome was absolute change in numeric pain scores during 0-24 and 24-48 hours after initiating IVL or EA, compared with baseline. Secondary outcomes include opioid consumption, incentive spirometry, supplemental oxygens, pneumonia, endotracheal intubation and length of hospital stay. RESULTS: Numeric pain scores differed at baseline (mean 5.6 for IVL vs 4.5 for EA, p=0.01), while age, injury severity, and number of fractured ribs were similar. IVL and EA were associated with similar reductions in numeric pain scores within 0-24 and 24-48 hours (mean -2.9 for IVL vs -2.3 for EA during both periods, p=0.19 and p=0.17 respectively) . There was greater non-neuraxial opioid consumption with IVL compared with EA (98.6 vs 22.3 mg morphine equivalents (MME) at 0-24 hours, p=0.0005; 105.6 vs 18.9 MME at 24-48 hours, p<0.0001). When epidural opioids were analyzed, the EA group was exposed to higher total MME at 0-24 hours (655.2 vs 98.6 MME, p<0.0001) and 24-48 hours (586 vs 105.6 MME, p=0.0001), suggesting an opioid sparing effect of IVL. CONCLUSION: Our results suggest that IVL is similar to EA in numeric pain score reduction, and that IVL may have an opioid sparing effect when taking neuraxial opioids into account. IVL may be an effective alternative to epidurals for the treatment of rib fracture pain. It should be considered for patients who have contraindications to epidurals or are unable to receive an epidural in a timely manner.
引用
- Lii TR, Aggarwal AK. Comparison of intravenous lidocaine versus epidural anesthesia for traumatic rib fracture pain: a retrospective cohort study. Reg Anesth Pain Med. 2020. PMID: 32503863. doi:10.1136/rapm-2019-101120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。